|
124 Companies |
|
161 Products |
|
161 Products |
|
116 Mechanisms of Action |
|
11 Trials |
|
2428 News |
|
| «12...2526272829303132333435...4950» |
- || amphotericin b liposome / Generic mfg.
New P3 trial, Combination therapy, Monotherapy: Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients. (clinicaltrials.gov) - Dec 12, 2013
P3, N=132, Not yet recruiting, Sponsor: Drugs for Neglected Diseases
- | Egrifta (tesamorelin acetate) / Theratechnologies, Massachusetts General Hospital
New P1 trial: Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients (clinicaltrials.gov) - Dec 12, 2013
P1, N=18, Completed, Sponsor: Theratechnologies
- Trial completion: HIV Prevention Program for African American Teen Males (clinicaltrials.gov) - Dec 12, 2013
P=N/A, N=840, Completed, Sponsor: University of Kentucky
Active, not recruiting --> Completed
- Trial completion: A Trial of the Efficacy and Safety of Topical Nitric Oxide in Patients With Anogenital Warts (clinicaltrials.gov) - Dec 11, 2013
P2, N=299, Completed, Sponsor: University of Aberdeen
Active, not recruiting --> Completed Not yet recruiting --> Completed
- Trial completion, Adherence: Evaluating Rewards-Based Adherence and Electronic Medication Monitoring in HIV-Positive Adolescents (clinicaltrials.gov) - Dec 11, 2013
P=N/A, N=100, Completed, Sponsor: St. Jude Children's Research Hospital
Not yet recruiting --> Completed Recruiting --> Completed
- | Intelence (etravirine) / J&J
Enrollment change: ETRALL;the ETRALL Trial: Prospective Evaluation of Etravirine for HIV-infected Patients in Need of Lipid-lowering Drugs (clinicaltrials.gov) - Dec 10, 2013
P3, N=34, Completed, Sponsor: Calmy Alexandra
Recruiting --> Completed N=44 --> 34
- azithromycin / Generic mfg.
Enrollment change: Effectiveness of HIV/Sexually Transmitted Infection Training for Physicians in China (clinicaltrials.gov) - Dec 10, 2013
P=N/A, N=1373, Completed, Sponsor: University of California, Los Angeles
N=44 --> 34 N=2640 --> 1373
- || Intelence (etravirine) / J&J
Trial completion: ETRALL;the ETRALL Trial: Prospective Evaluation of Etravirine for HIV-infected Patients in Need of Lipid-lowering Drugs (clinicaltrials.gov) - Dec 10, 2013
P3, N=34, Completed, Sponsor: Calmy Alexandra
N=2640 --> 1373 Recruiting --> Completed
- Trial completion: Effectiveness of Community-Level Behavioral and Biomedical Interventions for Reducing HIV/STIs in Men in Peru (clinicaltrials.gov) - Dec 10, 2013
P=N/A, N=718, Completed, Sponsor: University of California, Los Angeles
Recruiting --> Completed Recruiting --> Completed
- Trial completion: HIV Counseling and Testing and Linkage to Care in Uganda (clinicaltrials.gov) - Dec 10, 2013
P=N/A, N=3415, Completed, Sponsor: University of California, Los Angeles
Recruiting --> Completed Active, not recruiting --> Completed
- azithromycin / Generic mfg.
Trial completion: Effectiveness of HIV/Sexually Transmitted Infection Training for Physicians in China (clinicaltrials.gov) - Dec 10, 2013
P=N/A, N=1373, Completed, Sponsor: University of California, Los Angeles
Active, not recruiting --> Completed Recruiting --> Completed
- | Trial completion: Community Mobilization, Mobile Testing, Same-Day Results, and Post-Test Support for HIV in Sub-Saharan Africa and Thailand (clinicaltrials.gov) - Dec 10, 2013
P3, N=192814, Completed, Sponsor: University of California, Los Angeles
Recruiting --> Completed Recruiting --> Completed
- Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
Enrollment change: Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women (clinicaltrials.gov) - Dec 9, 2013
P4, N=105, Completed, Sponsor: University of Witwatersrand, South Africa
Recruiting --> Completed N=200 --> 105
- Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
Trial completion: Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women (clinicaltrials.gov) - Dec 9, 2013
P4, N=105, Completed, Sponsor: University of Witwatersrand, South Africa
N=200 --> 105 Not yet recruiting --> Completed
- Enrollment change: Autologous Dendritic Cell Vaccine in HIV1 Infection (clinicaltrials.gov) - Dec 8, 2013
P1/2, N=11, Completed, Sponsor: Sharon Riddler
Not yet recruiting --> Completed N=24 --> 11
- topiramate / Generic mfg.
Enrollment closed: Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy Drinkers (clinicaltrials.gov) - Dec 8, 2013
P2, N=60, Active, not recruiting, Sponsor: University of Pennsylvania
N=24 --> 11 Recruiting --> Active, not recruiting
- Enrollment closed: Effect of Diet-induced Weight Loss on HIV-associated Metabolic Syndrome (clinicaltrials.gov) - Dec 8, 2013
P=N/A, N=52, Active, not recruiting, Sponsor: Washington University School of Medicine
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Trial completion: Cognitive Stimulation Program in AIDS (clinicaltrials.gov) - Dec 8, 2013
P1, N=60, Completed, Sponsor: University of Pittsburgh
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Trial completion: Autologous Dendritic Cell Vaccine in HIV1 Infection (clinicaltrials.gov) - Dec 8, 2013
P1/2, N=11, Completed, Sponsor: Sharon Riddler
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change, Adherence: Telephone Support to Improve Adherence to Anti-HIV Medications (clinicaltrials.gov) - Dec 4, 2013
P2, N=59, Completed, Sponsor: AIDS Clinical Trials Group
Active, not recruiting --> Completed N=296 --> 59
- Enrollment open: X LIBRIS: X-linked Biological Response to HIV Sensing: the ANRS EP 53 Study (clinicaltrials.gov) - Dec 4, 2013
P=N/A, N=90, Recruiting, Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
N=296 --> 59 Not yet recruiting --> Recruiting
- | Enrollment closed, Adherence: DASH: Durability of Adherence in Self-Management of HIV (clinicaltrials.gov) - Dec 4, 2013
P3, N=213, Active, not recruiting, Sponsor: AIDS Clinical Trials Group
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Trial completion: EXTATIC: Antiretroviral Therapy and Extreme Weight (clinicaltrials.gov) - Dec 4, 2013
P=N/A, N=140, Completed, Sponsor: Hopital Lariboisi
Recruiting --> Active, not recruiting Recruiting --> Completed
- Trial completion: Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults (clinicaltrials.gov) - Dec 4, 2013
P=N/A, N=500, Completed, Sponsor: AIDS Clinical Trials Group
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion, Adherence: Telephone Support to Improve Adherence to Anti-HIV Medications (clinicaltrials.gov) - Dec 4, 2013
P2, N=59, Completed, Sponsor: AIDS Clinical Trials Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Isentress (raltegravir) / Merck (MSD)
Trial completion, IO biomarker: Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters (clinicaltrials.gov) - Dec 4, 2013
P=N/A, N=334, Completed, Sponsor: AIDS Clinical Trials Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion, IO biomarker: Long-Term Data Collection From Participants in Adult AIDS Clinical Trials (clinicaltrials.gov) - Dec 4, 2013
P=N/A, N=5982, Completed, Sponsor: AIDS Clinical Trials Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial termination: Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection (clinicaltrials.gov) - Dec 2, 2013
P=N/A, N=158, Terminated, Sponsor: Bayside Health
Active, not recruiting --> Completed Recruiting --> Terminated
- Enrollment change: Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection (clinicaltrials.gov) - Dec 2, 2013
P=N/A, N=158, Terminated, Sponsor: Bayside Health
Recruiting --> Terminated N=200 --> 158
- lopinavir/ritonavir / Generic mfg.
Enrollment closed: Molecular Diversity of HIV-1 Group O Strains and Treatment Management in Cameroon (clinicaltrials.gov) - Dec 2, 2013
P=N/A, N=171, Active, not recruiting, Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
N=200 --> 158 Recruiting --> Active, not recruiting
- Trial completion: Safety of Acidform Lubricant in HIV-Uninfected Women (clinicaltrials.gov) - Dec 1, 2013
P1, N=35, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Active, not recruiting Recruiting --> Completed
- | Viracept (nelfinavir) / ViiV Healthcare, Roche
Trial completion: When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study) (clinicaltrials.gov) - Dec 1, 2013
P3, N=300, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed Active, not recruiting --> Completed
- GSK2838232 / GSK
Enrollment change: Single Dose Escalation Study of GSK2838232 in Healthy Subjects (clinicaltrials.gov) - Nov 26, 2013
P1, N=17, Completed, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed N=84 --> 17
- Enrollment change: HIVBLD: Human Immune Responses Toward HIV-1 Envelope Antigens (clinicaltrials.gov) - Nov 26, 2013
P=N/A, N=8, Active, not recruiting, Sponsor: St. Jude Children's Research Hospital
N=84 --> 17 N=63 --> 8
- || Enrollment change: Subclinical Atherosclerosis in HIV-infected Patients (clinicaltrials.gov) - Nov 26, 2013
P=N/A, N=263, Completed, Sponsor: Massachusetts General Hospital
N=63 --> 8 N=340 --> 263
- Enrollment closed: HIVBLD: Human Immune Responses Toward HIV-1 Envelope Antigens (clinicaltrials.gov) - Nov 26, 2013
P=N/A, N=8, Active, not recruiting, Sponsor: St. Jude Children's Research Hospital
N=340 --> 263 Recruiting --> Active, not recruiting
- | GSK2838232 / GSK
Trial completion: Single Dose Escalation Study of GSK2838232 in Healthy Subjects (clinicaltrials.gov) - Nov 26, 2013
P1, N=17, Completed, Sponsor: GlaxoSmithKline
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||| Trial completion: Subclinical Atherosclerosis in HIV-infected Patients (clinicaltrials.gov) - Nov 26, 2013
P=N/A, N=263, Completed, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed Recruiting --> Completed
- Trial completion: QTVIE: Comparison of the QT/QTc Interval Between an Outpatient HIV-Infected Population on Antiretroviral Therapy and Two Large HIV-Negative Cohorts (clinicaltrials.gov) - Nov 24, 2013
P=N/A, N=160, Completed, Sponsor: Centre hospitalier de l'Universit
Recruiting --> Completed Recruiting --> Completed
- Trial completion: CDC HIV Testing Guidelines: Unresolved Ethical Concerns (clinicaltrials.gov) - Nov 24, 2013
P=N/A, N=1000, Completed, Sponsor: Rhode Island Hospital
Recruiting --> Completed Active, not recruiting --> Completed
- Clinical: PARC: Pre-ART Retention in Care in Tanzania (clinicaltrials.gov) - Nov 21, 2013
P=N/A, N=964, Active, not recruiting, Sponsor: Columbia University
- atorvastatin / Generic mfg.
Trial withdrawal: Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial (clinicaltrials.gov) - Nov 19, 2013
P2/3, N=0, Withdrawn, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Active, not recruiting --> Completed Not yet recruiting --> Withdrawn
- atorvastatin / Generic mfg.
Enrollment change: Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial (clinicaltrials.gov) - Nov 19, 2013
P2/3, N=0, Withdrawn, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Not yet recruiting --> Withdrawn N=100 --> 0
- | Isentress (raltegravir) / Merck (MSD)
New P4 trial, Combination therapy: Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-na (clinicaltrials.gov) - Nov 19, 2013
P4, N=100, Recruiting, Sponsor: Taipei Veterans General Hospital, Taiwan
- Isentress (raltegravir) / Merck (MSD)
Enrollment change, HEOR: Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266) (clinicaltrials.gov) - Nov 18, 2013
P=N/A, N=134, Completed, Sponsor: Merck
N=100 --> 0 N=395 --> 134
- Enrollment change: Study of Provider Computer Alerts Designed to Improve Delivery of HIV Care (clinicaltrials.gov) - Nov 18, 2013
P=N/A, N=1011, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
N=395 --> 134 N=800 --> 1011
- Enrollment change: Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as Promised (clinicaltrials.gov) - Nov 18, 2013
P1, N=58, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
N=800 --> 1011 N=92 --> 58
- Isentress (raltegravir) / Merck (MSD)
Trial completion, HEOR: Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266) (clinicaltrials.gov) - Nov 18, 2013
P=N/A, N=134, Completed, Sponsor: Merck
N=92 --> 58 Active, not recruiting --> Completed
- || Stribild (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate) / Gilead, Japan Tobacco
Trial completion: Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients (clinicaltrials.gov) - Nov 18, 2013
P3b, N=48, Completed, Sponsor: Gilead Sciences
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Study of Provider Computer Alerts Designed to Improve Delivery of HIV Care (clinicaltrials.gov) - Nov 18, 2013
P=N/A, N=1011, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Not yet recruiting --> Completed